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Abstract
Substance use is highly prevalent in the United States, and although treatments designed
to reduce substance use have shown promise, relapse rates between 40% and 70% following
treatment have been reported in recent studies. Given the high rate and chronicity of relapse
following substance abuse treatment, conducting research aimed to develop techniques to lower
the risk of relapse following treatment is imperative. A promising option to reduce relapse is to
use treatment reminder cues, or cues that are salient features of the treatment environment that
can be used to extend the effects of treatment into non-treatment settings. This study investigated
the effects of treatment reminder cues on rates of relapse in 50 male and female individuals
entering intensive outpatient treatment for substance abuse. It utilized a one-month randomized
and controlled design using state-of-the-art electronic handheld computer technology.
Participants in the experimental condition were prompted to read and respond to four treatment
reminder cues per day in addition to one daily diary survey assessing for a variety of proximal
variables related to relapse. All participants were asked to complete assessment questionnaires of
relevant variables that may affect relapse at baseline and 1-month follow-up. Chi-square tests
were used to determine if adding treatment reminder cues to standard treatment resulted in less
relapse relative to standard treatment alone, and whether onset occurred significantly later for
those receiving treatment reminder cues. Binary logistic regression analyses investigated the
extent to which compliance with treatment reminder cues was associated with relapse. Results
indicated that twice as many individuals in the control group relapsed compared to the
experimental group, which approached statistical significance. In addition, those in the
experimental group relapsed substantially later than did those in the control group. Results
indicated no effect of increased compliance on decreased relapse. Overall, this study holds the
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promise of providing a simple, inexpensive, and effective strategy for attenuating rates of relapse
or delaying the onset of return to use by extending the context of treatment beyond the
immediate therapeutic setting. Clinical and research implications, and future directions for
substance abuse research are discussed.
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Chapter 1
Introduction and Literature Review
Severity of Substance Use and Significance of the Problem
Substance use and abuse are highly prevalent in the United States and present major
public health concerns. In 2012, the Substance Abuse and Mental Health Administration’s
(SAMHSA) National Survey on Drug Use and Health found that more than 52% of individuals
12 years and older reported having consumed alcohol during that year, that nearly one quarter of
respondents indicated binge drinking within the last month, and that an additional 6.5% of
respondents engaged in heavy alcohol use (SAMHSA, 2012). Furthermore, 9.2% of the
population reported illicit drug use within the last month, of which the majority (63%) reported
marijuana as their primary drug of choice (SAMHSA, 2012). Given the high prevalence in the
population, it is not surprising that substance use disorders are among the most common of the
psychiatric disorders (Kessler et al., 2005). SAMHSA estimated that in 2012, 8.5% of the
population met diagnostic criteria for a substance abuse or dependence disorder. Of these, the
majority (14.9 million individuals) were diagnosed with dependence or abuse of alcohol only.
An additional 4.5 million were diagnosed with dependence or abuse of an illicit substance, and
2.8 million were abusing or dependent upon both alcohol and illicit drugs (SAMHSA, 2012).
Most individuals with a substance abuse or dependence disorder (7.3 million people) reported
marijuana as their primary drug, followed by pain relievers (2.1 million people), cocaine (1.1
million people), tranquilizers (630,000 people), stimulants (535,000 people), heroin (467,000
people), hallucinogens (330,000 people), inhalants (164,000 people), and sedatives (135,000
people; SAMHSA, 2012).
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Not only do substance abuse and dependence disorders have high prevalence rates, but
they are also associated with a host of co-morbid medical and psychological problems, including
panic reactions, paranoia, delirium, depression, alterations in memory, difficulty paying
attention, impaired executive functioning, employment and relational difficulties, suicide, and
partner violence (see Leri, Bruneau, & Stewart, 2003; Sussman, Stacy, Dent, Simon, & Johnson,
1996 for reviews). Furthermore, the cost of substance abuse and addiction to society is
substantial, and the National Institute of Health (NIH) estimates that substance related problems
cost the United States over $559 billion dollars per year due to increased healthcare costs, crime,
and lost productivity (NIH, 2004). Tobacco use accounts for the largest portion of this cost, at an
estimated $193 billion/year, but is followed closely by alcohol related problems ($185
billion/year) and illegal drug use ($181 billion/year; NIH, 2004). In addition, alcohol-related
accidents amount to a cost exceeding $100 billion per year. With regard to crime more
specifically, the National Partnership on Alcohol Misuse and Crime (NPAMC, 2013) reported
that almost 13,000 people are killed each year in an alcohol-related accident, that hundreds of
thousands are injured, that nearly 1.4 million people are arrested for driving while intoxicated
(DWI), of which 780,000 are convicted, and that, impressively, two-thirds of those sentenced for
DWI are repeat offenders. Violent crimes are also often associated with alcohol use and 40% of
convicted prisoners were under the influence of alcohol at the time of their offense (NPAMC,
2013). Statistics of the association between drug use and crime paints a similarly bleak picture.
According to the Uniform Crime Reporting Program (UCRP), nearly 1.7 million drug related
arrests were made in 2009 (NCADD, 2013). Additionally, 35% of prisoners in 2004 reported
committing an offense to obtain money for drugs (Bureau of Justice Statistics, 2004), and in
2007, nearly 4% of homicides were narcotics-related (NCADD, 2013). Despite the staggering
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negative psychological, social, relational, and legal consequences associated with substance
abuse, of the 22.2 million individuals suffering from a substance abuse or dependence disorder in
2012, only 4 million sought substance abuse treatment. Of these, the majority received treatment
for alcohol only, followed by treatment for both alcohol and drugs, and treatment for illicit drug
use only (SAMHSA, 2012).
Compounding the issues highlighted above is the finding that some substance abusers
continue illicit drug and alcohol use while undergoing substance abuse treatment. For instance,
in a study of 100 participants in methadone treatment, results indicated that although alcohol use
in this population decreased marginally, both the use of cannabis and the use of cocaine
increased significantly, as did the use of non-prescribed methadone (Best et al., 2000). This
finding is consistent with previous research that suggests that high rates of cocaine use are
common in individuals undergoing heroin treatment (e.g., Grella, Anglin, & Wugalter, 1997;
Magura, Kang, Nwakeze, & Demsky, 1998). Similarly, in a meta-analysis of the predictors of
continued drug use during and after treatment for opiate addiction, researchers found that a high
number of patients either relapsed following opiate treatment or continued drug use while in the
therapeutic setting (Brewer, Catalano, Haggerty, Gainey, & Fleming, 1998). In a chart-review
study of individuals attending inpatient substance abuse treatment, Greenfield, Weiss, and
Griffin (1992) found that 42 of the 700 participants continued to use drugs while in treatment,
and that the majority of these individuals had histories of either heroin or methadone abuse prior
to treatment.
Risk of Relapse following Treatment
Coupled with the risk of continued use while in treatment, the exceedingly high rates of
relapse following treatment are alarming. Although treatments designed to reduce substance use
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have shown promise, studies estimate that between 40% and 70% of people relapse following
treatment, and that 50% do so within the first six months (Dennis, Scott, & Funk, 2003; McKay
& Weiss, 2001; Project MATCH Research Group, 1997), with an additional 40% cycling
through periods of recovery and relapse (Scott, Foss, & Dennis, 2005). In an investigation of the
rates and predictors of relapse, Moos and Moos (2006) found that short-term remission rates
ranged from 20% to 50%. More specifically, Miller, Walters, and Bennett (2001) conducted a
review of the effectiveness of alcohol treatment and concluded that after one treatment episode,
one in four individuals abstained from further alcohol use during the first year post-treatment. In
addition, one in ten reduced the frequency and quantity of their drinking but continued with some
degree of use. Together, these cases accounted for approximately one third of individuals
undergoing treatment. The remaining two thirds of treated individuals continued to engage in
periods of heavy alcohol use. However, the authors noted that although these individuals
continued to consume alcohol, they tended to do so at a frequency significantly less than prior to
treatment, and drank fewer drinks per occasion. Alcohol related problems also decreased by 60%
following treatment (Miller et al., 2001). Comparatively, approximately 5%-45% of untreated
individuals are able to abstain from substance use on their own (Moos & Moos, 2006), although
this number is inflated in some studies to upwards of 80% depending on the severity of the
alcohol problem (Moos & Moos, 2006). In a meta-analysis comparing un-treated to treated
individuals, Moyer and Finney (2002) found that the rate of abstinence for un-treated individuals
was 21% compared to 43% for those who had undergone treatment. Similarly, Weisner,
Matzger, and Kaskutas (2003) found that treated individuals had higher treatment outcomes than
did untreated individuals (40% versus 23%).
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Overall, research seems to suggest that treated individuals fare better than do those that
do not seek substance use treatment (Moos & Moos, 2006). Research findings also suggest that
time in treatment is a primary predictor of treatment success (Moos & Moos, 2006) and that
patients who choose not to complete treatment or have shorter stays tend to experience higher
rates of readmission (Moos, Pettit, & Gruber, 1995). Furthermore, drop-out rates are a significant
concern during substance treatment, with approximately 10-30% of clients choosing to leave
treatment before its completion (Rabinowitz & Marjefsky, 1998). Studies examining the factors
associated with substance treatment drop-out have identified a number of important variables;
including, younger age (Cahill, Adinoff, Hosig, Muller, & Pulliam, 2003), African American
ethnicity (Milligan, Nich, & Carroll, 2004), less education (Siqueland et al., 1998), and
unemployment (Mertens & Weisner, 2000). More drug use (Mertens & Weisner, 2000) and
lower cognitive functioning (Erwin & Hunter, 1984), have also been identified as significant
predictors of drop-out. A number of in-treatment factors are also important in predicting dropout; including, therapeutic alliance and level of engagement in treatment (Joe, Simpson,
Dansereau, & Rowan-Szal, 2001). The literature on predictors of relapse to substance use mirror
the above findings and additionally highlight the role of increased interpersonal stress and
rejection sensitivity (Leach & Kranzler, 2013), reduced coping skills (McKay, Franklin, Patapis,
& Lynch, 2006), temptation to drink (Witkiewitz, 2013), and increased cravings and negative
affect (Witkiewitz & Marlatt, 2004) in increasing the risk for relapse.
Theoretical Models of Relapse
An interesting line of research suggests that the high rates of relapse can be partially
explained by the complexities inherent in the change process (Connor, Symons, Feeney, Young,
& Wiles, 2007), and many models have been developed to identify and explain the predictors of
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substance use relapse. These models can be classified into two broad groups; the psychological
models of relapse, and the psychobiological models of relapse. The Psychological group is
comprised of the cognitive-behavioral model (Marlatt & Gordon, 1985), the person-situation
interactional model (Litman, 1986), the cognitive appraisals model (Sanchez-Craig, 1976), and
the self-efficacy and outcomes expectations model (Annis, 1986; Rollnick & Heather, 1982;
Wilson, 1978). The psychobiological models of relapse include theories examining the roles of
opponent-process and acquired motivation (Solomon, 1980), craving and loss of control (Ludwig
& Wikler, 1974), urges and cravings (Wise, 1988), withdrawal (Mossberg, Liljeberg, & Borg,
1985), post-acute withdrawal syndrome (Gorski & Miller, 1979), and withdrawal/limbic kindling
(Adinoff, O’Neill, & Ballenger, 1995).
According to the Litman’s person-situation model, the interaction of an individual’s
coping skills, their perception of the effectiveness of these coping skills, and the ability of these
skills to mitigate a particular high-risk situation (e.g., negative mood, situations related to
drinking, interpersonal anxiety, decreased cognitive vigilance, rationalization for drinking) is key
to predicting and preventing relapse (Connors, Maisto, & Zywiak, 1996). More specifically,
relapse is a process that happens within an individual as the interaction between the three
aforementioned variables occurs. Relapse is therefore more likely to happen when an individual
feels to be lacking necessary coping skills with which to handle a particular high-risk situation.
In extension, those individuals who encounter more high-risk situations and possess the fewest
adequate coping strategies are more likely to relapse (Connors et al., 1996).
The focus of the cognitive appraisals model is somewhat different in that the person’s
appraisal of the high-risk situation is deemed most critical (Sanchez-Craig, 1976). According to
this model, the high-risk situation is not in and of itself a critical component to relapse; it is the
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individual’s interpretation of that situation that can lead to, or protect against, relapse (Connors et
al., 1996). In essence, a person can evaluate a situation either negatively, positively, or neutrally.
These perceptions may not be accurate and are subject to change as information becomes
available. These appraisals can also be affected by the availability of coping resources, and a
lack of coping strategies can lead to negative interpretations that are most predictive of relapse
(Connors et al., 1996).
The self-efficacy and outcome expectations model is drawn from the work of Bandura
(1977, 1982) and focuses on a person’s belief about the most likely outcome of a behavior
(outcome expectancies) and the evaluation of their ability to produce the behavior that will lead
to a particular outcome (self-efficacy; Connors et al., 1996). Both positive and negative outcome
and self-efficacy beliefs can affect the risk of relapse following treatment. For instance, an
individual may believe that they are able to abstain from drinking (a positive self-efficacy
belief), which may be countered by the belief that they will be unable to control their drinking
following the first sip (a negative self-efficacy belief; Connors et al., 1996). Similarly, outcome
expectancies can be both positive and negative, such that an individual may believe that
abstinence will follow treatment (positive) but that a full blown relapse will occur if even one sip
is taken (negative). The more the individual relies on the negative expectancies and beliefs and
the less control that individuals feels to have, the more likely relapse is to occur (Connors et al.,
1996).
Within the domain of psychobiological models, Solomon (1980) focused primarily on the
role of opponent-process and acquired motivation on the risk for relapse. According to the
opponent-process theory, when a person is exposed to a novel situation, the body acts to mitigate
the effects of the new stimulation. This new stimulus triggers a process that leads to a particular
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emotional state, but also triggers an opposing process that works to counteract the initial
emotional state. The ending emotion that the individual experiences is the combination of these
two processes (Solomon, 1980). Upon repeated exposure to the stimulus, the initial emotional
process becomes weakened and the secondary and opposing emotional process becomes more
dominant (Connors et al., 1996). When applied to substance use, the substance acts as the
stimulus. The initial response process may include a feeling of relaxation and happiness, whereas
the opposing process may include depression and irritability. For light drinkers, the effects of the
initial emotional process last longer, while for heavy drinkers, the extinction of the initial
emotional reaction occurs faster, causing the opposing emotional process to appear more quickly
and more dominantly. In heavy substance users, either one of these processes can lead to relapse;
the individual may seek to increase the positive emotions by engaging in more frequent
substance use, or may drink to seek relief from the negative emotional states caused by the
opposing process (Connors et al., 1996).
The carvings and loss of control model advocated by Ludwig and Wikler (1974) posits
that internal and external cues can lead to cravings and, by extension, to relapse. Internal cues
can include negative mood states as well as physical symptoms of substance withdrawal whereas
external cues may include the availability of the substance or the occurrence of a stress-inducing
situation (Ludwig & Wikler, 1974). The presence of these cues elicits cravings, which are seen
as a ‘cognitive label’ for the physiological arousal resulting from the presence of the cues, and an
individual’s appraisal of this arousal determines whether or not a ‘craving’ is present (Connors et
al., 1996). If a ‘craving’ is experienced, a person may seek relief from this arousal by using the
substance which may result in loss of control if that person were to be unable to interpret the
interoceptive cues that would facilitate regulation (Ludwig & Wikler, 1974).
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Similarly, Wise (1988) and Tiffany (1990) highlight the importance of cravings in their
models of relapse. According to these models, automatic and non-automatic cognitive processing
is critical in protecting against, or leading to, relapse (Connors et al., 1996). Automatic processes
are those that control most of our daily lives and are developed through repeated practice. Most
substance use behavior is controlled by these automatic processes (Tiffany, 1990). Cravings
develop through the process of substance withdrawal, or through the positive reinforcing effects
of the substance, and repeated exposure leads to automatic responding. Conversely, nonautomatic processes require conscious effort and involve choosing between strategies, executing
the chosen strategy, and maintaining the effects (Tiffany, 1990). As such, a substance user’s
ability to abstain from substances will be effortful since the automatic processes compel that
individual to use, and efforts to abstain must be consciously and willfully made (Connors et al.,
1996). For individuals in which non-automatic processing is absent or otherwise occupied,
relapse becomes more likely.
Several models have also focused on the importance of withdrawal in initiating relapse.
For instance, Mossberg et al., (1985) state that acute withdrawal is followed by 4-8 weeks during
which many negative side effects are experienced (e.g., depression, loss of concentration, and
anxiety). This period is followed by 1-3 weeks during which drastic mood changes occur and
during which relapse is most likely (Mossberg et al., 1985). Similarly, Gorski and Miller (1979)
focused their research on post-acute withdrawal syndrome and defined relapse as a “process that
occurs within the patient which manifests in a progressive pattern of behavior that allows the
symptoms of a disease or illness to become reactivated in a person that has previously arrested
those symptoms” (Groski & Miller, 1979, p1). According to their theory, repeated consumption
of a substance will lead it to have a normalizing effect on the person’s body. Upon abstinence,
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the body goes through a period of withdrawal. This withdrawal is followed by a period of up to 3
months during which ‘post acute withdrawal syndrome’ is experienced. This period is marked by
a decrease in higher level cognitive functioning, periods of emotionality, and poor decisionmaking, including the decision to relapse (Connors et al., 1996). At a more molecular level,
Adinoff et al. (1995) suggest that substance use potentiates the effects of the GABA
neurotransmitter which results in neuron inhibition (Connors et al., 1996). Upon abstinence from
the substance, the neuron becomes dis-inhibited leading to physiological changes associated with
withdrawal. Repeated withdrawal leads to increased physiological changes and more severe
symptoms. Over time, the individual experiences an effect called ‘kindling’ whereby the
individual begins to develop spontaneous symptoms of withdrawal in response to a number of
cues. The individual then experiences cravings and is motivated to use the substance to alleviate
the symptoms of withdrawal (Adinoff et al., 1995).
One of the most widely accepted models of relapse and the most widely cited model todate is the cognitive-behavioral model proposed by Marlatt and Gordon in 1985. The primary
components of this model are the self-efficacy that develops as a result of abstinence and the
availability of adequate coping resources. In other words, if an individual is unable to use
effective coping methods during a high-risk situation, their sense of self-efficacy decreases and
the attractiveness of substance use as a coping mechanism increases (Connors et al., 1996). More
specifically, the initial act of abstaining from a substance is believed to engender a sense of
efficacy and personal control, beliefs that become stronger as the period of abstinence increases.
However, as the period of abstinence continues, an individual is likely to come in contact with
increasingly more frequent high-risk situations. If the individual possesses adequate coping
skills, they are able to effectively navigate these situations resulting in continued abstinence and
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increased self efficacy (Bandura, 1977). However, if the individual does not possess adequate
coping skills, they are likely to experience a reduction in self efficacy and will be more likely to
turn to substances as an alternative coping mechanism (Marlatt & Gordon, 1985).
The origins of this model lie in a taxonomy of relapse situations developed by Marlatt
and Gordon in 1980 (Witkiewitz, 2011). This taxonomy was based on interviews with
individuals who experienced relapse following treatment and consisted of three hierarchically
arranged levels of 1) the intra- and inter-personal precipitants to relapse, 2) eight additional
categories within level 1 of the antecedents within the precipitants (e.g., coping with negative
emotions, testing personal control, giving in to temptations, social pressure), and 3) additional
subcategories of five of the eight categories in level 2 (Witkiewitz, 2011). Both the relapse
taxonomy and the relapse model have been influential in the field of substance abuse and relapse
and the taxonomy was tested for reliability and validity in classifying relapse episodes
(Witkiewitz, 2011). Rigorous testing enumerated significant problems in reliability, construct
validity, and predictive validity (Longabaugh, Rubin, Stout, Zyawiak, & Lowman, 1996; Maisto,
Connors, & Zywiak, 1996; Stout, Longabaugh, & Rubin, 1996).
Following the recommendation for a revised conceptualization, Witkiewitz and Marlatt
(2004) proposed the new cognitive-behavioral model of relapse as a nonlinear and dynamic
system (Witkiewitz, 2011). This model drew from past research of relapse risk factors (e.g.,
Connors et al., 1996, Shiffman et al., 1997) and adopted the terminology of distal and proximal
risk factors proposed by Shiffman in 1989 (Donovan, 1996). This revised model highlights the
importance of the temporal relationship between these distal and proximal affective, behavioral,
and cognitive factors during high-risk situations (Witkiewitz & Marlatt, 2004; 2007). Witkiewitz
and Marlatt (2004) define high-risk situations as “circumstances in which an individual’s attempt
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to refrain from a particular behavior (ranging from any use of a substance to heavy or harmful
use) is threatened” (Witkiewitz & Marlatt, 2004, p. 224-5). Within this model, distal risk factors
are enduring characteristics of the individual (i.e., coping skills) or of the environment (i.e. highstress) that increase the risk of relapse. Proximal variables are those that occur immediately
before relapse and complete the distal predisposition (i.e., cravings, negative affect). In addition,
these risk factors may operate either as tonic (i.e. stable factors) or phasic (transient precipitants;
Grace, 2000). For instance, Shiffman et al. (1997) noted that momentary beliefs in self-efficacy
(i.e. phasic) predicted smoking relapse above and beyond a person’s baseline level of selfefficacy (i.e., tonic).
Although research into the distal factors associated with relapse are inconclusive, likely
due to their indirect effect on relapse and reliance on the presence of a proximal risk factor,
McKay et al. (2006) have found that psychopathology, chronic stress, and poor social support
affect rates of relapse. In an early study of the effects of distal risk factors such as background,
cognitive variables, coping resources, life events, and pre-treatment characteristics on relapse
concluded that all variables with the exception of life events were significantly associated with
relapse, although proximal variables proved to be stronger predictors than did distal factors
(Miller, Westergerg, Harris & Tonigan, 1996). In a similar study, Connors and colleagues (1996)
found that background characteristics, treatment, coping skills, and alcohol use were significant
predictors of relapse but that the indirect effects of the distal variables were relatively small.
These findings are supportive of Witkiewitz and Marlatt’s theory in that distal factors may not
directly influence relapse, but rather influence relapse through their interaction with proximal
variables.
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Much more research has focused on the proximal variables associate with relapse and
studies assessing affective factors generally have found that positive mood predicts lower relapse
whereas negative mood predicts greater relapse (e.g., Mckay & Weiss, 2001; Tate, Brown,
Unrod, & Ramo, 2004). In relation to cognitive factors, studies have shown that attributions
following relapse, motivation for abstinence, self-efficacy, and cravings predict relapse (e.g.,
McKay & Weiss, 2001; Moore et al., 2013). Interpersonal factors have also been examined as
proximal variables and personal problems and perceived criticism from partners tend to precede
relapse (O’Farrell, Hooley, Fals-Stewart, & Cutter, 1998). According to theory, it is the
interaction of these distal and proximal risk factors that may be present in high-risk situations
that lead to relapse. For instance, a depressed person (distal factor) may experience a conflict
with their significant other and as a result experience negative affect and cravings (proximal
factor), which, taken together, increase the risk for relapse. As such, devising methods to extend
traditional treatments to be more temporally linked to these post-treatment, high-risk situations
may reduce relapse.
Treatment Reminder Cues
A promising option to reduce relapse is to use treatment reminder cues, or cues that are
salient features of the treatment environment that facilitate the retrieval of memories regarding
the effects of treatment when presented outside of the treatment context (Havermans & Jansen,
2003). This phenomenon has attracted a great deal of attention due to its important clinical
implication; mainly that therapeutic benefits of treatment may be limited to the environment in
which they were gained (Rodriguez, Craske, Mineka, & Hladek, 1999; Thomas, Drobes, & Deas,
2005; Denniston, Chang, & Miller, 2003). Bouton and Ricker (1993) found that treatment
context plays an important role in relapse, in that a setting more closely related to the original
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treatment setting is less likely to trigger cravings and relapse than a setting drastically different
from that of the treatment environment. Therefore, when a salient feature of the treatment
context is presented in a context other than that of treatment, the chance for relapse may be
greatly reduced. Treatment reminder cues are ideal for extending the treatment context beyond
the original treatment setting by reminding patients of salient concepts learned in treatment.
Evidence of the effectiveness of extending treatment to non-treatment contexts can be
found in literature examining the effects of homework and booster sessions. Researchers have
theorized that homework serves to generalize the therapy into other contexts of day-to-day living
(Garland & Scott, 2002; Kazantzis, Deane, & Ronan, 2000). Furthermore, Mausbach and
colleagues (2010) suggest that therapies found to be effective for anxiety disorders (Hofmann &
Smits, 2008), depression (Spek et al., 2007), and substance use disorders (Duttra et al., 2008)
may attribute their success to the use of homework as a mechanism to increase treatment
outcome (Mausbach et al., 2010). The authors suggest that homework allows clients to practice
strategies deemed helpful in alleviating symptoms, master skills in a natural setting, and promote
outcome by extending the treatment beyond therapy (Kazantzis & Lampropoulos, 2002). In the
first review of its kind assessing the effects of assigning homework, Kazantzis et al. (2000)
found that homework was significantly and positively related to therapy outcome and that
therapy outcome was predicted by homework compliance and completion. Mausbach et al.
(2010) corroborated these findings in an updated meta-analysis. Results of their review indicated
that increased homework compliance was associated with better treatment outcomes across a
number of target symptoms, including substance use. With regard to specific substances, in a
study investigating the effects of homework in treatment for cocaine dependence, Carroll, Nich,
and Ball (2005) found that participants who completed more homework assignments used
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significantly less cocaine during treatment and through a 1-year follow-up. Similarly, Gonzalez,
Schmitz, and DeLaune (2006) found that homework compliance predicted reduced cocaine use
following treatment, a relationship that was moderated by readiness to change. Taken together,
these results suggest that expanding the treatment context is vital in allowing patients to
generalize from treatment to their daily lives.
Similar evidence has been shown in research on the effects of booster sessions. Booster
sessions have long been advocated as a maintenance strategy under the belief that continued
indirect contact with the treatment context will help maintain treatment gains (Eysenck, 1963).
Studies examining the effects of booster sessions on a number of psychological conditions
revealed that, in general, booster sessions were found to be valuable in maintaining treatment
outcomes and in increasing positive change. For instance, in a study examining the effects of
booster sessions for depressed adolescents, the authors conclude that the sessions were helpful in
improving upon the gains made during treatment and helped to accelerate recovery for those who
did not respond to the initial treatment (Clarke, Rhode, Iewinsohn, Hops, & Deeley, 1999).
Similarly, Baggs and Spence (1990) found that booster sessions following assertiveness training
were also effective in enhancing the improvements made during the initial treatment.
Booster sessions have also been found to be effective following treatment for substance
abuse and dependence. An early study on the effects of booster sessions for alcoholics found that
the median number of days to relapse was significantly higher for those receiving booster
sessions than for those not receiving booster sessions (Vogler, Lunde, Johnson, & Martin, 1970).
A more recent study revealed that women randomized to receive booster sessions and life skills
training as treatment enhancers showed significant reductions in alcohol use 18 months after
treatment than did women who received only life skills training. The results provide support that
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booster sessions can be employed as treatment enhancement strategies to reduce problematic
alcohol use (Connors & Walitzer, 2001). Similarly, McCrady, Epstein, and Kahler (2004) found
that among participants in a relapse prevention (i.e. booster sessions) program following alcohol
behavior couples therapy fared better than those participating in Alcoholics Anonymous
following treatment. More specifically, the more booster sessions a participant attended, the
better their treatment outcome (McCrady et al., 2004). The authors also highlighted the
importance of engaging clients in after-care strategies to help maintain the treatment effects and
prevent relapse (McCrady et al., 2004).
Booster sessions provided via telephone have recently gained in popularity and do show
to be effective. For instance, an investigation of the use of telephone booster sessions during
smoking cessation treatment showed that participants engaged in both treatment and booster
sessions were twice as likely to quit smoking as participants only engaged in treatment but not
booster sessions (Metz et al., 2005). In a review of 5 studies and over 9,000 participants
regarding the effectiveness of text messages as booster sessions during smoking cessation,
Whittaker et al. (2011) found that text messages increased the chance of quitting from 4% to 5%
in the control group, and from 6% to 10% in groups receiving text messages. These texts
provided motivation and encouragement and offered practical advice on how to manage cravings
and high-risk situations (Whittaker et al., 2011). Taken together, the literature suggests that
providing continued reinforcement in the form of extending treatment is effective, lending
further support to the possible effectiveness of using treatment reminder cues as a primary
reinforcement mechanism. However, much research is left to be done specifically regarding the
effects of booster or reminder strategies following substance abuse treatment. Although the use
of booster sessions and homework has been shown to be effective, these methodologies are
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discontinued or occur infrequently once standard treatment ends, thus increasing risk for relapse.
Treatment reminder cues provide a cost effective modality for extending treatment to other
contexts and beyond the time when standard treatment discontinues. Fortunately, with the advent
of handheld computers we can now assess treatment reminder cues and their effectiveness as a
relapse prevention tool in a more precise and comprehensive manner.
Ecological Momentary Assessments (EMA)
Given the significant drawbacks of retrospective reporting, assessment strategies that rely
on momentary ‘real-time’ data collection are becoming more and more popular (Shiffman,
Stone, & Hufford, 2008). As described by Shiffman et al. (2008), ecological momentary
assessments address these pitfalls by examining behavior in real time and in the individual’s
natural environment. Most often, EMA studies involve collecting data throughout the day as the
participant is going about their normal routine (Shiffman, 2009). EMA studies are especially
indicated when a particular behavior, such as alcohol use, is of interest. As such, EMA studies
have investigated a wide variety of symptoms, including eating disorders (Goldschmidt et al.,
2014), trait anxiety and trait anger (Edmondson et al., 2013), trauma (Kleim, Graham, Bryant, &
Ehlers, 2013), and mood disorders (aan het Rot, Hogenelst, & Schoevers, 2012). EMA studies
have also proven particularly fruitful in studies of drug and alcohol use (Shiffman, 2009). Given
the episodic and discrete nature of substance use, it lends itself particularly well to the eventoriented assessment provided by EMAs (Shiffman, 2009). In addition, given the research
regarding the importance of proximal variables to substance use and relapse, momentary
assessment of the immediate precursors to use is critical in understanding an individual’s internal
and external motivations. A concern regarding the use of an EMA protocol is its relatively
substantial demand with regard to participant compliance. A legitimate argument is that
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substance users may not be motivated or willing to comply with these requirements given their
propensity for comorbid psychiatric conditions, their often chaotic lifestyles, and their general
non-adherence to treatments (Shiffman, 2009). However, research consistently demonstrates that
EMAs are indeed an effective tool to use with a substance using population. For instance,
Freedman, Lester, McNamara, Milby, and Schumacher (2006) examined the utility of EMAs
delivered via cell phone among a population of homeless crack-cocaine addicts. Their results
showed an impressive compliance rate of 77% despite the demanding protocol of responding to
phone calls every 3 hours day and night for 14 days. This study also evidenced a low dropout
rate of 10% with an average dropout time of 1 day early, and a low rate of lost cell phones (only
1 in 30 was lost; Freedman et al., 2006). Epstein et al. (2009) also obtained good compliance
rates over a 6 month period with crack and heroin users undergoing treatment. Similarly,
Johnson, Barrault, Nadeau, and Swendsen et al. (2009) found EMAs to be effective for use with
opiate abusing women, and Hopper et al. (2006) found EMAs to be effective with ecstasy users
who were also concomitantly using alcohol, cannabis, cocaine, and hallucinogens. Taken
together, these studies alleviate any doubt that EMAs are inappropriate for use with a substance
abusing population and lend strong support for their utility.
EMAs and the Assessment of Relapse
The use of EMAs administered via handheld computers and diary technology have been
studied for their ability to assess risk factors for daily use and relapse among individuals seeking
treatment for smoking, and studies have shown that participants respond to at least 90% of
random prompts (5 daily) for up to one month (e.g., Gwaltney, Shiffman, Balabanis, & Paty,
2005; Stone & Shiffman, 2002). Gwaltney et al. (2005) also found that lower self-efficacy within
certain situations predicted relapse if such situations were present. Moreover, Shiffman et al.
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(2007) found that whereas daily changes in negative affect did not predict smoking lapses,
increases in negative affect were reported within a few hours of smoking lapses using electronic
diaries. Taken together, these studies demonstrate high compliance rates to EMA protocols and
provide strong support for their applicability in obtaining insights into relapse not obtainable
through traditional assessment methods.
The use of handheld computer technology has also proven informative in studies of
alcohol. For instance, an early study conducted by Litt, Cooney, and Morse (1998) used
programmable watches to prompt participants to complete assessments and although the results
are primarily methodological, the watches were deemed to be successful in prompting
assessment responses. More recently, Krahn, Bohn, Henk, Grossman, and Gosnell (2005)
recruited 68 alcohol-dependent men who used handheld computers to answer random prompts
four times daily for 14 days about urges to drink and positive and negative affect. Results of
cluster analyses showed that the largest cluster of participants reported low mean urge levels and
low variability of urges during early abstinence. Similarly, Cooney et al. (2007) recruited 102
alcohol-dependent patients from outpatient substance abuse programs. Participants used
handheld computers for 14 days to respond to four random prompts assessing mood states and
cravings. Patients responded to 73% of the random prompts. Results showed that mood did not
predict relapse, but a trend was found for cravings to predict relapse. In a sample of participants
entering treatment for concurrent cocaine and heroin use, Epstein and colleagues (2009) found
that cravings and negative affect were related to cocaine relapse and feeling worried was
associated with heroin relapse. In a study of patients with concurrent alcohol and tobacco use,
Holt, Litt, and Cooney (2012) assessed antecedents to first drink using handheld computers over
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a 28 day period. The authors reported a compliance rate of 65% and found that drinking relapse
was preceded by lower confidence to resists cravings.
Most significantly, the EMA investigation of the effects of cravings and affect on risk for
relapse following substance use treatment conducted by Moore et al. (2013) informed both the
design and the methodology of this project. The author held an integral role in this prospective,
longitudinal grant-funded study investigating the use of handheld computer technology to assess
the proximal variables surrounding relapse. The Moore et al. study examined proximal variables
related to relapse among a sample of 100 men and women entering outpatient treatment at
Cornerstone of Recovery, the same facility in which this current study was conducted. Handheld
computers prompted participants four times daily for four months regarding a variety of
proximal variables. Participants also completed assessment measures at baseline and 2- and 4month follow-ups. Descriptive analyses indicated a compliance rate of 47% with the diaries
(over 10,000 received), 92% with the 2-month follow-up packet, and 79% with the 4-month
follow-up packet. Overall, relapse occurred in 42% of the experimental participants and 48% of
the control participants (not significantly different). Hierarchical linear modeling (HLM)
revealed that cravings and negative affect such as anger and stress were significantly temporally
associated with relapse. These studies suggest that patients in substance abuse treatment will
respond sufficiently to handheld computer prompting and that using such technology could be
valuable for assessing the process of relapse.
Rationale for the Proposed Study and Significance
Given the high prevalence of substance dependence and relapse, it is vital to develop
effective means to extend standard treatment in a cost effective and minimally time consuming
manner to reduce relapse. Using diary technology has been shown to be feasible and to evidence
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excellent compliance rates (up to 98%) in studies examining factors associated with daily
substance use (e.g., Carney, Armeli, Tennen, Affleck, & O’Neil, 2000; Hussong, 2007),
suggesting that this methodology holds promise in the present study. This methodology is also
effective in greatly increasing the frequency and quantity of obtainable data while reducing the
burden placed upon the participants. More specifically, treatment reminder cues provide a cost
effective modality for extending treatment to other contexts and beyond the time when standard
treatment discontinues. This project is particularly innovative in that it is the first known study
using handheld computers to administer these treatment reminder cues as a form of relapse
prevention to patients entering treatment based on an Alcoholics Anonymous (AA) approach. As
part of the standard AA treatment program, patients are repeatedly exposed to phrases associated
with treatment (e.g., 90 meetings in 90 days, call your sponsor). Over time, these phrases become
synonymous with treatment and become cues or salient features of the treatment that may reduce
relapse when presented following termination of standard treatment. Treatment reminder cues
presented on handheld devices provide an ideal mechanism by which to extend the treatment
context beyond the original treatment setting. By extending the effect of treatment into an
individual’s natural environment, it follows that treatment reminders may be effective in
attenuating the rates of relapse, or at the least, delay the onset of relapse to substance use. As
such, the overarching goal of the this study is to determine the extent to which electronic
treatment reminder cues administered via handheld computers are effective in extending
treatment gains into post-treatment environments and in reducing relapse. A secondary goal of
this study is to explore the extent to which distal factors (e.g., psychopathology, self-efficacy)
and proximal factors (e.g., cravings, negative affect) influence the impact of treatment reminder
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cues on rates of relapse, as well as the association between treatment reminder cue compliance
and relapse. The specific hypotheses are:
Hypothesis 1. Adding treatment reminder cues to standard outpatient treatment will
result in less relapse relative to standard outpatient treatment alone.
Hypothesis 2. When relapse happens, its onset will occur significantly later for those
who received standard outpatient treatment plus reminder cues relative to those who received
standard outpatient treatment alone.
Hypothesis 3. Greater compliance with responding to treatment reminder cues will be
associated with lower relapse.
The examination of the effectiveness of treatment reminder cues represents a new and
innovative approach to attenuating relapse following substance abuse treatment and will provide
information to increase the efficacy of relapse prevention programming. The finding that
treatment reminder cues serve to reduce the risk for relapse following treatment could be used by
prevention programs to greatly enhance the effects of formal treatment upon traditional treatment
termination. Additionally, the finding that handheld computers are effective in distributing
treatment reminders and reducing relapse, could lead to their use as a tool to administer more
complex and formal treatments and further reduce treatment related costs and significantly
reduce relapse rates. Furthermore, this study has the potential to inform future research using
other technological avenues to disseminating psychological interventions (e.g., mobile
telephones). Given the recent electronic health movement, providing an inexpensive avenue for
mental health treatment that allows a greater majority of individuals to obtain treatment is
becoming increasingly important. This project has the potential to provide vital information on
the feasibility and effectiveness of interventions provided electronically. Lastly, this study is the
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first investigating handheld technology in the context of substance abuse treatment and could
lead to numerous future studies designed to improve substance abuse treatments.
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Chapter 2
Methods
Overall Strategy
This study utilized a one-month randomized-controlled design to investigate the extent to
which treatment reminder cues reduced relapse at a greater rate than standard care among 50
men and women completing substance abuse treatment at Cornerstone of Recovery. This design
used state-of-the-art electronic handheld computers involving random exposure to treatment
reminder cues four times daily for one month. Electronic surveys were also administered once
daily to assess cravings, negative affect, and substance use (Appendix A). For the initial contact,
all participants completed questionnaires of variables that may affect relapse and received
training in using a handheld computer. Participants were then randomly assigned to the
experimental (standard treatment plus treatment reminder cues) or control condition (standard
treatment only). Subsequently, participants completed a 1-month follow-up assessment.
Design considerations. In preparing for this study, several design features were carefully
considered, the first of which was the most appropriate frequency for participants to receive
treatment reminders cues. The goal was to select a frequency that minimized burden to
participants while maximizing effects of exposure to treatment cues on preventing relapse.
Studies using 5-8 random daily prompts showed compliance rates of approximately 86%
(Hufford, Shields, Shiffman, Paty, & Balabanis, 2002; Litt et al., 1998). In an ecological
momentary assessment study conducted by Moore et al. (2013), results showed a 47%
compliance rate when prompts were presented four times per day for four months and took 5
minutes to complete. As such, in the present study, random treatment reminder cues were
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presented four times per day, along with a daily diary assessment. The time required for
participants to respond to the treatment reminder cue was one minute or less per prompt.
A second design consideration was the type of control group to be utilized in this study.
In our previous study (i.e., Moore et al., 2013), the control group did not receive a handheld
computer but completed the baseline and follow-up assessments. The commensurate relapse
rates between the experimental (42%) and control (48%) conditions indicated that simply having
the handheld computer did not affect rates of relapse, suggesting that being assigned a handheld
in and of itself did not increase or decrease risk for relapse. Therefore, for this study, a control
group that did not receive the handheld computer and only completed the baseline and follow-up
assessments was utilized.
A third consideration was the best method for defining relapse. There is considerable
discord in the literature with some studies using “any” substance use, and some using “heavy”
consumption to define relapse. In this study, “relapse” was operationalized as an initial return to
any substance use (consistent with an AA treatment model used at the study location). Given that
relapse rates above 40% were found in the preliminary study, there will be sufficient power to
assess the effectiveness of adding treatment reminder cues using this approach to operationalize
relapse.
Preliminary Studies
Focus group to identify effective treatment reminder cue messages. In preparation for
this study, the author conducted a focus group at Cornerstone of Recovery. The focus group was
designed to gather information regarding the content of the treatment reminders. The focus group
generated a list of 140 phrases identified as salient by patients and staff. A formal survey with
these phrases was then created and administered to 59 patients at the treatment facility. The
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participants were asked to rate each of the phrases on a scale of 1 (not important for recovery) to
5 (very important for recovery). Following the focus group, the phrases were narrowed down to
94 phrases that participants found most useful in their recovery (i.e., average rating of 3 or
greater; Appendix B). Each prompt used a different randomly-selected cue and all participants
received the same cues at the same time.
Participants
Participants were 50 patients entering the Intensive Outpatient Program (IOP) for
substance abuse treatment at Cornerstone. Cornerstone accepts approximately 160 new adult
patients into the IOP program each year and provides activity therapy, group therapy, education
groups, stress management, and family therapy following a 12-step recovery model. Treatment
lasts approximately 4 to 8 weeks. Patients were eligible to participate if they were at least 18
years old, able to speak English (to ensure comprehension of research materials), receiving
treatment for alcohol or an illicit drug, and did not meet criteria for a psychotic disorder. Patients
of all ethnic groups were eligible to participate. Participants were recruited upon entering
treatment via a member of the investigative team. This member was on-site twice weekly to meet
with patients who were informed of the study by treatment staff; a method that was found to be
effective in the preliminary study. Interested patients participated in a brief screening interview
and received a detailed overview of the project. Eligible participants were then randomly
assigned to the treatment or control conditions and were scheduled for the baseline assessment
and electronic diary training at Cornerstone.
Based on prior studies, we expected to be able to complete follow-up interviews with
80% of the participants enrolled in the study over a 1-month period. Every effort was made to
increase compliance and decrease attrition over the course of the study. To reduce attrition,
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participants received financial compensation. Participants earned $5 for completing the baseline
assessment, $0.50 for each treatment reminder cue that they completed within one hour of
prompting, $1.00 per completed daily diary, and $5 for completing the follow-up assessment.
Other steps to reduce attrition included gathering contact information for relatives or friends who
served as locators if there was particular difficulty contacting a participant, as well as promptly
compensating participants.
Procedures
Patients interested in participating received a detailed overview of the project and
payment schedule and were asked for their consent to participate in a brief screening interview.
If the inclusion criteria described above were met, participants completed informed consent
procedures (Appendix C). Once informed consent was secured, participants were asked to
complete a packet of surveys (see measures below). Participants were then randomly assigned to
the experimental and control conditions and those in the experimental condition received training
on how to operate their handheld computer and how to read and respond to the treatment
reminder cues and daily surveys. Participants used HP iPAQ 110 handheld computers to respond
to reminder cues and daily diary prompts. The handheld computers possessed a free wireless
account for transferring data to a computer in the lab following each entry. Consistent with the
preliminary study, a schedule was developed with each participant for weekly meetings at
Cornerstone with the researcher while in treatment. This meeting was designed to provide
payment for participation and address problems that arose during the course of the study. Upon
completion of treatment (e.g., 4 weeks), participants returned the handheld device and completed
the 1-month follow-up assessment.
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Measures
Assessments focused on four domains: a) screening measure, b) measures of
demographic and distal variables, c) treatment reminder cues, and d) electronic diaries.
Screening Measure. During the screening interview, participants provided information
to determine eligibility (i.e., age, language). Participants also responded to questions regarding
past and current psychosis. Participants who met criteria for past or current psychosis were ruled
out of the study and referred back to their treatment provider (Appendix D).
Demographic and Distal Measures. At baseline, participants completed a demographics
questionnaire (e.g., education level, religion, ethnicity) and a number of relevant distal measures
related to risk for relapse (Appendix E). The Structured Clinical Interview for DSM-IV (SCID-P;
First, Spitzer, Gibbon, & Williams, 1995) was administered to assess diagnostic criteria for
substance use and other Axis I psychopathology (Appendix F). Adequate reliability of the SCID
has been demonstrated (First et al., 1995). This measure was administered by a trained graduate
student research assistant (RA). The first five interviews were observed by the researcher to
ensure compliance with assessment directions.
Substance use. The Alcohol Use Disorders Identification Test (AUDIT; World Health
Organization, 1982) is a simple tool used to identify people at risk for alcohol problems. This
measure was utilized in this study as a method to assess relapse. It boasts a 92% sensitivity and
94% specificity (Appendix G). Similarly, the Drug Use Disorders Identification Test (DUDIT;
Berman, Bergman, Palmstierna, & Schlyter, 2005) is used to identify individuals at risk for drug
use. It predicts dependence with a sensitivity of 90% and specificity at 88%. Its reliability
coefficient is 0.80 (Berman et al., 2005l; Appendix H).
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Social support. Perceived social support was assessed with the Social Support
Questionnaire (SSQ; Sarason, Levine, Basham, & Sarason 1983), which measures availability of
and satisfaction with social supports. This tool also has excellent reliability and validity estimates
(Appendix I).
Affect. The Positive and Negative Affect Scale (PANAS; Watson, Clark, & Tellegen,
1988) was used to assess various positive and negative moods on a number of time scales. Its
alpha reliabilities are high, ranging from 0.86 to 0.90 for positive affect and 0.84 to 0.87 for
negative affect (Watson et al., 1988; Appendix J).
Treatment Reminder Cues. The treatment reminder cues were administered four times
daily via the HP iPAQ 110 handheld computer using the SnapSurvey software package. The
content of the reminder cues was randomly generated from the database containing the phrases
identified via the focus group and subsequent surveys gathered at Cornerstone as being
particularly salient in participants’ recoveries (see Preliminary Studies). Ninety-four possible
phrases were stored in the database. With 112 treatment reminder prompts over one month,
participants were exposed to each prompt between 1 and 2 times. Participants were asked to
respond to the treatment reminder cues by completing a multiple choice question indicating
which treatment reminder cue they were exposed to. This ensured that participants were
attending to the reminder cues. Responding to the question associated with each cue took less
than one minute. The handheld computers’ alarm clocks were programmed to generate an
automatic prompt for the participant to read and respond to the cues. This software was ideal for
this study, as it allowed information to be sent via wireless encrypted communication to a standalone secure computer and avoided frequent lab visits to download data. Participants were
thoroughly trained in responding to reminder cues and no prior experience using a computer was
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necessary. Assistance was provided on an as-needed basis and a member of the research team
was on-site twice weekly to address any problems. Compliance was tracked with SnapSurvey
software.
Electronic Diary Questionnaire. Participants were prompted once daily to complete the
Electronic Diary Questionnaire. Many of the questions were adapted from well-validated
measures, such as the Positive and Negative Affect Scales (Watson et al., 1988) to assess affect.
This prompt occurred at a pre-determined time indicated by each participant. SnapSurvey
directed participants to answer questions about past 24-hour affect, cravings, triggers for craving,
and substance use. If substance use occurred, participants were prompted to indicate the type of
substance used, trigger(s) for use, and time use began and ended. Participants were able to
indicate if more than one period of craving and/or substance use occurred and to answer relevant
questions for each episode. All participants were trained during baseline in quantifying drinks
and categorizing classes of drugs. This combination of prompts and questions maximized the
likelihood of assessing events preceding relapse. Additionally, using the electronic diary
questionnaire allowed for a more accurate assessment of whether relapse occurred and the extent
to which exposure and responses to treatment reminder cues were temporally linked to relapse.
Because clients were not be asked to report use when responding to the treatment reminder cues,
utilizing the daily questionnaire was vital in assessing factors temporally associated with relapse.
Identifying Relapse. All participants in the study were informed of confidentiality
procedures regarding reporting relapse. An agreement with Cornerstone provided that participant
relapse did not need to be reported to treatment staff in an effort to ensure maximum disclosure.
Unless reported verbally by a participant during the study, sources of reported relapse were not
analyzed until after the study’s completion at which time several strategies were used to identify
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relapse. First, participants in the experimental condition were asked to report relapse via the daily
diary on their handheld computers; second, all participants were asked to report relapse on the
AUDIT and DUDIT included in their follow-up packets; and third, a thorough review of
Cornerstone’s online medical health records was conducted to determine whether participants
relapsed during the study but failed to report it via study material, or after leaving the treatment
facility following treatment termination.
Data Management and Storage. Data management and data entry were conducted by
trained RAs under the guidance of the author. Each response to a treatment reminder cue and
electronic diary entry was automatically sent via wireless communication from the handheld
computer to a password-protected computer for data storage. Project data collected at baseline
and one-month follow-ups were double coded by multiple research assistants to ensure
reliability.
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Chapter 3
Results
Descriptive Statistics: Overall Sample
Overall, 50 participants were included in data analysis; 25 in the experimental condition,
and 25 in the control condition. For the entire sample, the average age was 37.20 (SD = 12.2)
(range = 18-63). More men (n=32) than women (n=18) participated in the study. The majority of
the sample identified as Caucasian (86%), with an additional 6% identifying as Black/AfricanAmerican, 4% Hispanic, and 4% Native American. Further, the majority of the overall sample
attended college or a professional school (40%), had an average annual income of $50,001 to
$100,000, were single (42%), identified as heterosexual (88%), identified as Non-Catholic
Christians (46%), and those in relationships were so for an average length of 72 months (see
Table 1 for detailed sample characteristics). Among the sample, 70% received an Alcohol
Dependence diagnosis and 60% received a Drug Dependence diagnosis (cannabis 10%, cocaine
10%, other stimulants 7%, opioids 27%, sedatives 3%, and poly drug dependence without
alcohol 43%).
Descriptive Statistics: Experimental Condition
Within the experimental group, the mean age was 33.6 (SD = 11.61). As in the overall
sample, 64% of the participants were male and 88% identified as Caucasian. The majority in this
group had only a high school education (40%), earned less than $25,000 per year, and were
unemployed. Most (48%) were single and identified as heterosexual (76%). Those in
relationships were partnered for an average of 52 months. Most (36%) identified as Non-Catholic
Christians. Within this group, 56% received an Alcohol Dependence diagnosis and 64% received
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Table 1
Participant Characteristics
Characteristic
Full Sample (N = 50)
Age (M, SD)
Sex (%)
Males
Females
Race (%)
Caucasian
African American
Hispanic
Native American
Education (%)
Grade school
High school diploma
Attended College
College degree
Graduate degree
Employment (%)
Unemployed/Disability
Employed part-time
Employed full-time
Annual Income (%)
Less than $25,000
$25,001 -$50,000
$50,001-$100,000
$100,001-$150,000
Greater than $150,001
Religion
Catholic
Non-Catholic Christian
Jewish
Other
Marital Status
Single
Dating
Married

M (SD) or %

37.2 (12.2)
64.00
36.00
86.00
6.00
4.00
4.00
4.00
32.00
40.00
14.00
10.00
48.00
4.00
48.00
28.00
20.00
34.00
16.00
2.00
22.00
46.00
2.00
30.00
42.00
6.00
30.00
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Table 1. Continued.
Characteristic
Separated
Divorced
Relationship length
Experimental Condition (N = 25)
Age (M, SD)
Sex (%)
Males
Females
Race (%)
Caucasian
African American
Hispanic
Education (%)
Grade school
High school diploma
Attended College
College degree
Graduate degree
Employment (%)
Unemployed/Disability
Employed part-time
Employed full-time
Annual Income (%)
Less than $25,000
$25,001 -$50,000
$50,001-$100,000
$100,001-$150,000
Religion
Catholic
Non-Catholic Christian
Jewish
Other
Marital Status
Single
Dating
Married

M (SD) or %
12.00
10.00
71.96 (111.83)

33.6 (11.61)
64.00
36.00
88.00
4.00
8.00
4.00
40.00
36.00
12.00
8.00
56.00
8.00
36.00
36.00
20.00
28.00
16.00
22.00
46.00
2.00
30.00
48.00
8.00
24.00
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Table 1. Continued.
Characteristic
Separated
Divorced
Relationship length
Control Condition (N = 25)
Age (M, SD)
Sex (%)
Males
Females
Race (%)
Caucasian
African American
Native American
Education (%)
Grade school
High school diploma
Attended College
College degree
Graduate degree
Employment (%)
Unemployed/Disability
Employed full-time
Annual Income (%)
Less than $25,000
$25,001 -$50,000
$50,001-$100,000
$100,001-$150,000
Greater than $150,001
Religion
Catholic
Non-Catholic Christian
Jewish
Other
Marital Status
Single
Dating
Married

M (SD) or %
8.00
12.00
51.64 (87.74)

40.80 (11.94)
64.00
36.00
84.00
8.00
8.00
4.00
24.00
44.00
16.00
12.00
40.00
60.00
20.00
20.00
40.00
16.00
4.00
8.00
60.00
4.00
28.00
36.00
4.00
36.00
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Table 1. Continued.
Characteristic
Separated
Divorced
Relationship length

M (SD) or %
16.00
8.00
92.28 (130.23)

a Drug Dependence diagnosis (cannabis 6%, cocaine 6%, other stimulants 13%, opioids 19%,
and poly drug dependence without alcohol 56%).
Descriptive Statistics: Control Condition
The mean age in the control group was slightly higher with a mean of 40.8 years (SD =
11.94). As in the experimental condition, 64% were men and 84% identified as Caucasian. This
group was also more educated, with the majority reporting attending college or professional
school. They also earned $50,001 to $100,000 per year and reported full time employment. An
equal percentage were single or married (36%), with an average relationship length of 92
months. All were heterosexual and reported being of Non-Catholic Christian faith. Among this
group, 84% received an Alcohol Dependence diagnosis and 56% receiving a Drug Dependence
diagnosis (cannabis 14%, cocaine 14%, opioids 36%, sedatives 7%, and poly drug dependence
without alcohol 29%).
Significant Differences across Conditions
Chi-square tests were used to determine whether significant differences existed across the
control and experimental conditions. No significant differences were found for gender,
education, ethnicity, religion, income, employment, marital status, or sexual orientation.
Independent sample t-tests were used to examine differences in age and relationship length
across the two conditions. Results showed that individuals in the control group tended to be older

37
than those in the experimental group t(48) = -2.162, p = 0.036. Those in the control condition
were also significantly more likely to have been diagnosed with an Alcohol Dependence
Disorder 2 (1) = 4.667, p = 0.031 but no group differences were found for frequency of drugrelated diagnoses, or differences in which drugs participants used (see Table 2).

Table 2
Demographic Differences across Conditions
Characteristic

2

Gender
Education
Ethnicity
Religion
Income
Employment
Marital status
Sexual orientation
Alcohol dependence
Drug dependence
Drug classifications

0.00
1.54
4.34
7.65
2.67
4.17
2.23
6.82
4.67*
0.33
5.55

Characteristic

t

Age
Relationship length

-2.13*
-1.29

Note. * p <.05

EMA Methods and Relapse
Hypothesis 1. Adding treatment reminder cues to standard outpatient treatment will
result in less relapse relative to standard outpatient treatment alone.
Relapse was defined as any return to substance use and was primarily identified via
Cornerstone of Recovery’s computerized medical records system. None of the participants
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reported relapse on the daily diaries on the handheld computers, or on the AUDIT and DUDIT
included in the follow-up packets. Within the overall sample, 11 out of 50 participants (22%)
relapsed during the study. A trend appeared for more individuals in the control group to relapse
compared to the experimental group, 2 (1) = 2.914, p = 0.08; three individuals in the
experimental group (12%) and eight in the control group (32%). Although this is not a
statistically significant difference, it potentially has important clinical implications that are
discussed below. No significant differences in terms of demographic variables were found
among those who relapsed during the study across the two conditions (see Table 3).

Table 3
Differences between Those Who Relapsed During the Study and Those Who Did Not Relapse
Characteristic

2

Gender
Education
Ethnicity
Religion
Income
Employment

4.66
1.01
2.30
6.92
7.00
3.62

Characteristic

t

Age
Relationship length

-1.04
-1.88
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Hypothesis 2. When relapse happens, its onset will occur significantly later for those
who received standard outpatient treatment plus reminder cues relative to those who received
standard outpatient treatment alone.
Time-to-relapse was defined as the amount of days after beginning the study in which a
participant relapsed. An independent t-test analysis was used to examine any statistical
differences across control and experimental group participants who relapsed while participating
in the study. Results revealed that the average amount of days to relapse was not significantly
different across the two groups, t(9) = 1.743, p = 0.115. The average length of time for
participants in the experimental group to relapse was 38 days (SD = 17.34, Range = 19 - 53) and
20 days (SD = 14.46, Range = 2 - 37) for those in the control group.
Importantly, four individuals originally in the experimental group relapsed after the study
concluded, whereas none of the control group participants relapsed following study completion.
Results showed that those in the experimental group who relapsed either during or after the
study relapsed later than those in the control group, representing a statistically significant
difference, t(13) = 2.685, p = 0.026. Furthermore, individuals who relapsed after the study did
not differ significantly on any demographic variables when compared to those who relapsed
during the study, indicating that the treatment reminder cues likely accounted for this delayed
return-to-use (see Table 4). Interestingly, those who relapsed regardless of whether during or
after the study, were in relationships of significantly shorter length than those who did not
relapse, t(48) = -2.234, p = 0.002 (see Table 5). Furthermore, those who relapsed did not differ
significantly with regard to size and quality of their support networks when compared to those
who did not relapse, t(45) = 0.85, p = 0.40 and t(48) = -0.78, p = 0.44, respectively.
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Table 4
Differences between Those Who Relapsed After the Study and Those Who Did Not Relapse
Characteristic

2

Gender
Education
Ethnicity
Religion
Income
Employment

0.37
1.77
0.71
1.86
1.70
1.81

Characteristic

t

Age
Relationship length

-1.10
-0.83

Table 5
Differences between All Who Relapsed and Those Who Did Not Relapse
Characteristic

2

Gender
Education
Ethnicity
Religion
Income
Employment

0.66
2.59
3.49
4.78
6.81
3.37

Characteristic

t

Age
Relationship length

-1.62
-2.23*

Note. * p <.05
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Compliance Rates
Hypothesis 3. Greater compliance with responding to treatment reminder cues will be
associated with lower relapse.
A total of 2,296 of 2,800 treatment reminder cues were answered (Mean = 87.48, SD =
29.5, Range = 14-112 out of 112 possible). The overall compliance rate for the treatment
reminder cues was 82%. In addition, of the 700 total daily diary entries, participants completed
511 daily surveys (Mean = 19.6, SD = 7.7, Range = 2-28 out of 28 possible), resulting in an
overall daily diary compliance rate of 73%. The compliance rate for completing the 1 month
follow-up assessment was 72%. A binary logistic regression was used to determine if relapse
rates for those who relapsed during the study differed based on the number of treatment cues to
which they responded. Results showed that increased compliance with treatment cues did not
significantly predict relapse, 2 (1) = 0.273, p = 0.601. A second logistic regression was used to
examine whether increased compliance was associated with relapse for those who relapsed after
the study. Again, results showed that increased compliance was not associated with relapse
following the study, 2 (1) = 0.881, p = 0.348. Similarly, results from a third logistic regression
showed that compliance rate was not associated with relapse for all individuals who relapsed,
regardless of whether they relapsed during or after the study, 2 (1) = 1.358, p = 0.244.
Effects of Cravings and Affect on Relapse
To examine the effects of cravings on risk for relapse, we conducted a series of
independent sample t-tests. Results indicated that average ratings of cravings for drugs or alcohol
did not differ significantly for those who relapsed during the study when compared to those who
did not relapse, t(489) = -1.045, p = 0.296. Average cravings also did not differ for those who
relapsed after the study when compared to those who did not relapse, t(489) = -0.639, p = 0.523,
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or when comparing all participants who relapsed to those who did not, t(489) = -1.256, p = 0.21.
Similarly, independent sample t-tests revealed that baseline levels of self reported positive and
negative affect were not significantly related to relapse (Table 6).

Table 6
Comparing Positive and Negative Affect for Those Who Relapsed Versus Those Who Did Not
Variable

t

All Relapse (N = 11)
Positive Affect
Negative Affect

0.87
0.58

Relapse During Study (N = 7)
Positive Affect
1.52
Negative Affect
0.32
Relapse After Study (N = 4)
Positive Affect
-0.82
Negative Affect
0.49
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Chapter 4
Discussion
The findings of this study broaden the literature on relapse prevention by being the first
to use handheld computers to test the extent to which they can be used as a tool to extend the
salient components of substance abuse treatment to non-treatment settings. It is also the first to
examine the use of treatment reminder cues as the means to present information learned during
treatment to settings outside of the immediate therapeutic environment in which an individual
may operate both during and after treatment. Given that a large percentage of individuals relapse
during and following treatment, this study is especially important in that it potentially provides a
cost efficient, simple, and effective strategy to ‘remind’ participants of the relapse-prevention
techniques they have learned during treatment while they are not actively engaged in treatment
or treatment-related activities.
Indeed, our results suggest that treatment reminder cues may be an effective way to
prevent and reduce relapse during intensive outpatient treatment. Although only a trend emerged
when comparing the rates of relapse of individuals in the control group versus those in the
experimental group, this finding has significant clinical implications. Specifically, more than
twice as many people in the control condition relapsed during the study than did people in the
experimental condition (eight versus three). Results also found that these individuals did not
differ significantly on any demographic variable. Taken together, and given that the only
difference across these groups was the use of the handheld computers to deliver treatment
reminder cues, suggests that these cues may be an effective way of attenuating relapse. It is
likely that the small sample size affected our power to detect statistically significant differences
in relapse, although the clinical significance is evident. Rosenthal’s (1995) investigation of the
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effectiveness of aspirin therapy highlights the distinction of clinical versus statistical significance
and illustrates that statistical information may only account for part of the value of a particular
finding. In his study, Rosenthal found that giving participants aspirin was so effective in
preventing heart attacks that it would have been unethical to continue providing a placebo
replacement to the control group. Interestingly, the effect size of the ability of aspirin to prevent
heart attacks was well below 0.2 which by today’s standards is considered a small effect. Despite
the small statistical impact of the aspirin intervention, the clinical implications of saving even
just one individual from a heart attack were too important to disregard. Although reducing
relapse may not be as broadly applicable as reducing heart attacks, the clinical value of reducing
relapse during substance abuse treatment by half is important to consider when examining the
utility of treatment reminder cues.
Although treatment reminder cues may be effective in attenuating relapse during
substance treatment, results from this study also showed that treatment reminder cues may be
effective in delaying relapse after treatment. More specifically, data showed that four individuals
in the experimental group relapsed after the study concluded whereas none in the control group
relapsed after study termination, and time-to-relapse analyses showed that those in the
experimental group relapsed significantly later than did those in the control group. Taken
together, these findings suggest that treatment reminder cues may be an effective tool in delaying
the onset of relapse, not only during treatment, but also after treatment completion. Given that
the treatment reminder cues were not actually presented outside of the IOP setting, yet still had
some carry-over effects after treatment, suggests that presenting cues while a participant is in
outpatient treatment is sufficient in generalizing the treatment outside of the immediate
therapeutic setting. In other words, presenting treatment reminder cues randomly throughout the
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day ensures that they are administered while the participant is in a variety of non-treatment
settings, allowing for the generalization of treatment reminder cues to a broad array of settings in
which patients may operate following treatment. As such, day-to-day settings become associated
with treatment in some salient way thereby reducing the likelihood of relapse.
Furthermore, we found that higher compliance, and by extension, more exposure to
treatment reminder cues was not significantly associated with reduced relapse. In other words,
those who responded to only a handful of reminder cues were no more likely to relapse than
those who responded to all 112 cues throughout the study. This suggests that even minimal
exposure to reminder cues can have effects on delaying relapse, and that there is likely some
generalizability across settings in which participants actively responded to cues. As an
illustrative example, for a participant who only responded to 20 cues while at work and while at
the IOP living facility, but not while in school at the local college, the treatment reminder cues to
which he responded may have provided enough of an extension of what he learned in treatment
to non-treatment related settings, to where the effects generalized from the work and IOP living
facility to also include the school environment in which he did not respond to reminder cues. As
such, responding to more cues may not have provided any additional benefits. A weakness to
these findings is the inability to identify in which environments participants received and
responded to their cues. An informative and important follow-up study would be one in which
participants are tracked with regard to where they are exposed to reminder cues to determine if
exposure while in certain settings allows for broader generalizability than others. Another
important topic for future research is whether there is a threshold for the amount of reminder
cues to be effective and at which point exposure to additional cues stops having additive value
with regard to relapse attenuation. Although more frequent exposure is not statistically related to
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decreased relapse, this study found that once treatment reminder cues were terminated for those
in the experimental condition, relapse rates increased to be nearly identical to those in the control
group. This suggests that longer, but not necessarily more, exposure to reminder cues is
necessary in order to maintain longer-term effects. Extended exposure allows for the reminder
cues to be presented in a more varied array of settings, increasing their generalizability to other
areas in which the patient may operate on a daily basis.
An interesting finding emerged when comparing those who did not relapse to those who
did, regardless of whether they relapsed during or after the study. Specifically, those who did not
relapse were in relationships of significantly longer length than those who did. Surprisingly,
these participants did not differ with regard to relationship status and were equally likely to be
single, married, or separated. They also did not differ with regard to baseline levels of perceived
social support or satisfaction with their support network. These findings suggest that being in
longer term relationships in and of itself may have protected against relapse regardless of the
perceived size and quality of a participant’s support network, and is in line with research on the
protective nature of long-term, committed relationships. For instance, literature shows that
marriage and committed long-term relationships provide a sense of well-being, emotional
support, and mutual reinforcements between individuals (Gove, Style, & Hughes, 1990; Kim &
McKenry, 2002), and that those in healthy long-term relationships tend to be happier and more
productive (Ren, 1997). In light of this research and despite the fact that marital status did not
protect our participants from substance addiction in the first place, it is possible that those in
longer term relationships were protected from relapse by virtue of having a more secure and
established family support system and perhaps more incentive to remain sober. Those in shorter
term relationships may experience more relational instability, less support from their significant
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other, and less extrinsic motivation to avoid relapse, making them more vulnerable to return to
substance use.
Overall, this study possessed a number of significant strengths that make it a valuable
asset in the relapse prevention literature. First, the use of handheld computers is cutting edge
methodology that is gaining in popularity among researchers. The use of state-of-the-art
technology afforded the opportunity to address limitations of retrospective studies (i.e.,
retrospective recall bias) and to administer the intervention in a minimally invasive and cost
effective manner with reduced concern for the potential that reactivity to assessment would
increase the relapse rate. Second, this study is the first to examining the effects of extending
treatment contexts by using reminder cues. Our findings from this study are promising for the
effectiveness of using this methodology to attenuate and delay relapse and set important
groundwork for future research in this area. Third, by demonstrating that patients in treatment
will provide frequent responses and can be highly compliant with the use of handheld devices,
this study also suggests that handheld computers may be of great utility for treatment delivery,
especially for patients who might otherwise not seek treatment or have limited capabilities to
attend treatment.
Although this study possesses a number of strengths, one limitation is that relapse was
only identified via the online medical records system and no participant reported relapse on their
handheld device. A likely explanation is that reporting relapse while in treatment at Cornerstone
has serious implications, including being removed from the IOP program. Although participants
were informed about confidentiality procedures, it is possible that some feared the negative
consequences associated with reporting and therefore avoided this type of disclosure while the
study was ongoing. However, Cornerstone maintains detailed online medical records, including
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results from drug screenings and peer reports of misconduct. In addition, staff conduct monthly
follow-up consults with each patient following treatment, during which they are asked to report
on sobriety and relapse. For this study, relapse data during and after the study duration were
gathered primarily from these online medical health records. To reduce this shortcoming, future
studies should use calendar-based interviewing to help participants remember certain events
through the use of specific time markers, as well as frequent biochemical verification, and
collateral reports.
Another limitation is the timeframe in which this study was conducted. Because
participants were only exposed to treatment reminder cues while in the IOP program, this study
did not capture the effects of treatment reminder cues when presented entirely outside of a
therapeutic setting. Although participants in IOP generally have jobs and social commitments,
their daily lives rarely resemble the typical experiences of a participant at home going through
their typical daily routines. As such, the generalizability of the effects of treatment reminder cues
may not extend beyond the time at which a participant leaves the IOP setting and returns to the
environments in which they previous engaged in substance use. An important follow-up study
would be one that examines the effects of reminder cues both while a participant is in treatment
and after a participant has returned home. Such a study would be better able to identify whether
the cues are salient enough to remind the participants of what they have learned in treatment
while they are no longer engaged in the formal treatment process.
Another limitation is the small sample size that did not provide sufficient power to detect
what may be significant effects of reminder cues on relapse. Power analyses using the G*Power
GUI (Faul, Erdfelder, Lang, & Buchner, 2007) revealed that a total sample of 88 participants (44
in each condition) would be necessary to detect statistically significant differences in relapse.
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Given that there is no agreed upon strategy for calculating effect sizes and conducting poweranalyses using multi-level models (e.g., see Roberts & Monaco, 2006), we assumed standard
regression models. This assumption is likely to provide a more conservative estimate of the
necessary sample size due to the power gained by numerous surveys from each person. Thus, we
calculated the necessary sample size needed to attain a medium effect (d=.30) with power of 0.8
and two-tailed significance tests of .05 (see Figure 1). Future research with larger samples and
more power could confirm that utilizing reminder cues does indeed significantly reduce the rates
of relapse.

Figure 1. Power Analysis
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Despite these limitations, results from this study provide a compelling basis for future
research on the ways in which treatment components can be introduced into non-treatment
settings and more specifically, how treatment reminder cues may be able to provide a nonintrusive, cost-efficient, and effective tool to do so. An area for future research is the utility of
combining treatment reminder cues with other electronic strategies in order to a) prevent or delay
relapse, and b) notify treatment providers of a client’s impeding likelihood of relapsing. A study
recently published by Moore et al. (2013) found that participants who experienced a sudden
increase in cravings were 14 times more likely to relapse than those who did not report such an
increase. Results also showed that those who reported lower average cravings throughout the
study were more likely to relapse following a sudden increase in cravings than were individuals
who reported higher but more steady cravings. Although in the present study we did not find
significant differences in average ratings of cravings among those who relapsed versus those
who did not, an important future study is one that delineates the effects of treatment reminder
cues on cravings prior to self-reported relapse to determine whether exposure to cues may lessen
average cravings or reduce the intensity of sudden spikes. The Moore et al. (2013) study also
found that those experiencing increases in negative affect were more likely to relapse than those
without such increases. Although in the present study we did not find that baseline levels of
positive and negative affect were significantly associated with relapse, we did not examine
fluctuations in affect throughout the study and did to assess for a temporal association between
affect and relapse. Future studies should assess for changes in affect throughout the study in
order to examine the effects of reminder cues on reducing negative affect and their combined
effect on relapse.
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Furthermore, the direction of substance use treatment specifically, but also of mental
health treatment in general, is headed towards an integration of technological advances in not
only the treatment of disorders, but also in their timely identification and prevention. Using
handheld devices allows for real-time information regarding the well-being of a client and allows
for timely notification for preventative action. Understanding the temporal connection between
proximal variables and relapse, as well as the utility of treatment reminder cues in reducing their
intensity will allow providers to engage in appropriate action between the moment cravings are
reported and before a patient can re-engage in substance use. Furthermore, treatment reminder
cues are not limited to handheld computers. Future research should examine their utility when
administered via text messages on mobile phones or via electronic mail. The ultimate goal of this
line of research is to identify an effective strategy to reduce or delay relapse that is easy to
administer, cost efficient, available to a wide variety of clients regardless of socioeconomic
status or life circumstance, and is able to reach patients who are not actively engaged in
treatment or those individuals who may otherwise not want to or be able to engage in formal
treatment at all.
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Appendix A
Daily Diary Questionnaire
(Perceived Stress)
1. In the last 24 hours, how often have you felt that you were unable to control the important
things in your life?
0
Never

1
almost never

2
sometimes

3
fairly often

4
very often

2. In the last 24 hours, how often have you felt nervous or “stressed”?
0
Never

1
almost never

2
sometimes

3
fairly often

4
very often

3. In the last 24 hours, how often have you felt that you were effectively coping with important
changes that were occurring in your life?
0
Never

1
almost never

2
sometimes

3
fairly often

4
very often

4. In the last 24 hours, how often have you felt confident about your ability to handle your
personal problems?
0
Never

1
almost never

2
sometimes

3
fairly often

4
very often

5. In the last 24 hours, how often have you felt that things were going your way?
0
Never

1
almost never

2
sometimes

3
fairly often

4
very often

6. In the last 24 hours, how often have you found that you could not cope with all the things that
you had to do?
0
Never

1
almost never

2
sometimes

3
fairly often

4
very often

7. In the last 24 hours, how often have you found yourself thinking about things that you have to
accomplish?
0
Never

1
almost never

2
sometimes

3
fairly often

4
very often
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8. In the last 24 hours, how often have you felt difficulties were piling up so high that you could
not overcome them?
0
Never

1
almost never

2
sometimes

3
fairly often

4
very often

(Craving)
1. In the last 24 hours, how strong was your strongest craving or desire for alcohol/drugs?
1
very slightly
or not at all

2
a little

3
moderately

4
quite a bit

5
extremely

(If score 2 or higher)
1a. At what time did you first notice the craving? (clock display will be presented)
1b. At what time was the craving strongest?
1c. At what time did the craving stop or mostly go away?
1d. Please indicate the primary or strongest trigger for the craving.
Bad Mood
Stress
Good Mood
Relaxing
Eating
Bar
Someone talking about alcohol/drugs
Argument/disagreement with someone

Boredom
Out of Nowhere
Fatigue/Tired
Physical Pain

1e. Please mark all the triggers involved in the craving.
Bad Mood
Stress
Good Mood
Relaxing
Eating
Bar
Someone talking about alcohol/drugs
Argument/disagreement with someone

Boredom
Out of Nowhere
Fatigue/Tired
Physical Pain

(Interpersonal Conflict)
1. In the last 24 hours, did you have a conflict, argument, or fight with anyone?
Yes / No
1a. If yes, how many conflicts did you experience in the last 24 hours?
1b. With which person did you experience the worst or most stressful/difficult conflict?
Intimate Partner
Father

Friend
Mother

Fellow Patient(s)
Sibling

Counselor
Child

70

1c. Thinking about the worst or most difficult conflict? At what time did this conflict
start?
1d. At what time did the conflict end?
1e. Did you experience a craving for alcohol/drugs as a result of this conflict? Yes / No
1f. How strong was the craving?
1
very slightly
or not at all

2
a little

3
moderately

4
quite a bit

5
extremely

(Substance use)
1. In the last 24 hours, did you drink alcohol?
Yes / No
1a. If yes, what time did you have your first drink?
1b. If yes, how many drinks did you consume?
1, 2, 3……50
1c. If yes, at what time was your last drink?
1d. Please indicate the primary or strongest trigger for using alcohol.
Bad Mood
Stress
Good Mood
Relaxing
Eating
Bar
Someone talking about alcohol/drugs
Argument/disagreement with someone

Boredom
Out of Nowhere
Fatigue/Tired
Physical Pain

1e. Please mark all the triggers involved in deciding to use alcohol.
Bad Mood
Stress
Good Mood
Relaxing
Eating
Bar
Someone talking about alcohol/drugs
Argument/disagreement with someone

Boredom
Out of Nowhere
Fatigue/Tired
Physical Pain

2. In the last 24 hours, did you use any of the following drugs? Select all that apply
Marijuana / Cocaine / Hallucinogens / Stimulants / Opiates /
Sedatives/Hypnotics (e.g., amobarbital, lorazepam) /
Anxiolytics (e.g., Xanax, Valium, Ativan) / Other / Did not use
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2a. If yes, what time did you start using _______? (will repeat for each drug used)
2b. If yes, at what time did you stop using _______?
2c. Please indicate the primary or strongest trigger for using _______.
Bad Mood
Stress
Good Mood
Relaxing
Eating
Bar
Someone talking about alcohol/drugs
Argument/disagreement with someone

Boredom
Out of Nowhere
Fatigue/Tired
Physical Pain

2d. Please mark all the triggers involved in deciding to use _______.
Bad Mood
Stress
Good Mood
Relaxing
Eating
Bar
Someone talking about alcohol/drugs
Argument/disagreement with someone

Boredom
Out of Nowhere
Fatigue/Tired
Physical Pain

(Motivation/Self-Efficacy)
1. For the last 24 hours, please indicate the extent to which you felt that maintaining abstinence
was important to you.
1
Not at all
Important

2
A little
Important

3
Moderately
Important

4
Quite
Important

5
Very
Important

2. How confident are you in your ability to maintain abstinence during the next 24 hours?
1
Not at all
Confident

2
A little
Confident

3
Moderately
Confident

4
Quite
Confident

5
Very
Confident

(Perceived Criticism)
1. In the last 24 hours, how critical do you think your spouse (or current partner) was of you?
Not at all
Critical
1
2

3

4

Moderately
Critical
5
6

7

8

Very Critical
Indeed
9
10

2. In the last 24 hours, how critical do you think you were of your spouse (or current partner)?
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Not at all
Critical
1
2

3

4

Moderately
Critical
5
6

7

8

Very Critical
Indeed
9
10

3. In the last 24 hours, how critical do you think your counselors were of you?
Not at all
Critical
1
2

3

4

Moderately
Critical
5
6

7

8

Very Critical
Indeed
9
10

4. In the last 24 hours, how critical do you think you were of your counselors?
Not at all
Critical
1
2

3

4

Moderately
Critical
5
6

7

8

Very Critical
Indeed
9
10

73
Appendix B
Database of Treatment Reminder Cues
Slow down and breathe.
Don’t get too far ahead of yourself.
Easy does it.
Are you working on your steps to recovery?
Keep it simple.
It is what it is.
Acceptance is the key to all my problems.
I need to stop and pray.
It is time to slow down.
Take care of yourself first.
Take time to meditate.
Have you done a 10th step today?
Have you called your sponsor?
Have you been grateful today?
Have you talked to an addict today?
The first thing I put in front of my recovery is the first thing that I will lose.
Be careful not to dwell on your past because it will become your future.
You are in recovery; or you are in relapse.
If you are not working on your recovery, your addiction is working on a relapse.
Surrender
Don’t use, no matter what.
If I keep doing what I always did, I’ll keep getting what I always got.
Have hope.
Remember to stay open-minded.
Did you pray today?
Play the tape all the way through.
Yesterday is history, tomorrow is a mystery, today is a present.
Remember what it was like before coming here.
Have you practiced spiritual principles?
1 is too many and 1000 are never enough.
What are you willing to do for your recovery?
Have you been to a meeting?
You can only change one thing: Everything.
Have you read from the Big Book?
Live just for today.
In order to keep it, did you give it away?
Stay in the moment.
Any life run on self-will can hardly be a success.
Take action.
Have you done a self inventory?
Resentment is the number one offender.
If you are not honest with yourself, you cannot be honest with others.
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How far are you willing to go for victory over your addiction?
The spiritual life is not just a theory. You have to live it.
Live and let live.
Unity, recovery, and service.
Surrender to become Victorious.
Be of maximum service to others.
When the pain of staying sober becomes less than the pain of getting drunk/high, you’ll stay
sober.
We'll love you, until you learn to love yourself.
90 meetings in 90 days.
Write a gratitude list and count your blessings.
Faith chases away fear.
A drug is a drug.
You can talk the talk, but can you walk the walk?
Live life on life's terms. Keep coming back, it works if you work it.
Death, insanity, or recovery.
Today "I" have a choice.
I didn't get into trouble every time I used, but every time I got in trouble I was using.
I came, I came to, I came to believe.
Insanity is defined as doing the same thing over, and over again, expecting different results.
We are without defense against the first use, our defense must come from a power greater than
ourselves.
Don't work my program, or your program, work "the program”.
If you want what we have and you’re willing to go to any lengths to get it.
The addict's mind is like a bad neighborhood, don't go there alone.
Gratitude, that's the attitude.
Faith without work is dead.
Get to the meeting early and go to the meeting after the meeting.
My worst day sober is better than my best day drunk/high.
Half measures availed us nothing.
None of us came here on a winning streak.
This too shall pass.
Once an addict always an addict.
I might have another drunk left in me, but do I have another recovery?
H.A.L.T. - Hungry, angry, lonely, tired.
F.E.A.R. – Face everything and recover.
Nothing changes if nothing changes.
H.O.W. - Honesty, open mindedness, willingness.
Take what you need and leave the rest.
It's the journey not the destination.
God will never give you more then you can handle.
Learn to listen and listen to learn.
Never alone, never again.
If you expect respect, be the first to show some.
Serenity is not freedom from the storm but peace amid the storm.
Keep coming back.
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Resentment is like drinking poison and expecting someone else to die.
You only get out of it what you put into it.
An addict alone is in bad company.
Humility is not thinking less of myself but thinking of myself less.
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Appendix C
Consent for Participation in a Research Project
Invitation to Participate and Description of Project
You are invited to participate in a research study designed to examine the effects of
treatment reminder cues, and to assess your mood, cravings, interpersonal experiences and
substance use while completing a substance use treatment program. You have been invited to
participate because you are completing an outpatient substance use treatment program, are at
least 18 years old, speak English, and are living at the facility while completing the treatment.
Your participation in the study will last approximately 90 minutes today and up to 10 minutes
each day for one month. Participation will involve completing a packet of questionnaires today,
followed by training in using a hand-held computer to answer a few questions each day for one
month while you complete your treatment. You will also be asked to meet with a member of the
research team each week and in one month to return the hand-held computer.
In order to decide whether or not you wish to be a part of this research study, you should
know enough about its risks and benefits to make an informed judgment. This consent form
gives you detailed information about the research study which a member of the research team
will discuss with you. This discussion should go over all aspects of this research: its purpose, the
procedures that will be performed, any risks of the procedures, possible benefits and possible
alternative treatments. Once you understand the study, you will be asked if you wish to
participate; if so, you will be asked to sign this form.
Description of Procedures
If you decide to participate, you will be asked to complete confidential questionnaires
regarding thoughts, feelings, and behaviors in relation to a number of areas, including mood,
substance use, and how you handle conflict in relationships. None of the information that you
provide will be shared with Cornerstone. After you complete the questionnaires, you will meet
with someone from the research team to receive 30 minutes of training in responding to
treatment reminder cues and in answering questions about mood, cravings, conflicts with other
people, and substance use on a hand-held computer. The purpose of this study is to use treatment
reminder cues to extend the effects of treatment to other non-treatment contexts, as well as to
better understand the daily experiences of men and women completing a substance use treatment
program. You will be asked to keep the handheld computer with you to answer a few questions
each day, send us your answers via wireless communication, meet with the researcher weekly to
collect your compensation, and to return in one month so that we can collect the computer. We
will also collect data from Cornerstone about you, such as your intake assessment battery and
results from drug screens. However, we will not share any information about you with anyone at
Cornerstone. We will also ask you to provide contact information so that we can locate you for
the follow-up meeting in one month.
Risks and Inconveniences
A risk of study participation is the possibility that providing information about mood,
substance use and conflicts with others will be upsetting to you. You may decide to end your
participation in the study at any time. Another potential risk is the loss of confidentiality.
Although none of the information you might share regarding your mood, conflict, or substance
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use will be shared with anyone, including counselors and staff at Cornerstone, your name will be
linked to the information you provide until the study is completed. To ensure that the information
you provide us remains confidential, it will be identified with a numeric code only and stored in
a locked file cabinet at the University of Tennessee. Only the research team will be able to
connect your name with your information during the study, and this will be used only for the
purpose of contacting you for the follow-up session. Once the study is complete, the file linking
your name with your information will be destroyed. In addition, only your numeric code and not
your name will be used on the hand-held computers and neither you nor other people will be able
to access your daily computer responses at anytime.
Confidentiality cannot be protected if child or elder abuse is suspected or reported.
Tennessee law does not require that we report illegal substance use or incidents of past conflict
or aggression between two adults, but we will need to inform the proper authorities if you or
someone else is in imminent danger of being injured or abused.
Benefits
A small benefit to this study is that participants will be able to use the various programs
on the hand-held computer throughout the duration of the study. Participants also have a chance
to contribute to a scientific study that may help people in the future. In addition, if participants
wish to be given referrals for additional counseling, a referral list is available upon request.
Economic Considerations
All participants will be paid $5 for completing the packet of questionnaires at the
beginning of the study. Participants will be paid up to $3.00 for each day they respond to
treatment reminder cues and diary questions. Finally, participants will be paid $5 for returning
the hand-held computer at the end of the study and completing the follow-up. However,
participants who withdraw from the study without returning the hand-held computer, return for
the follow-up assessment without the hand-held computer (because it was lost, stolen, etc.), or
return with a computer that has clearly been damaged will only receive compensation for
responses to treatment reminder cues and daily surveys already received by the research team.
Therefore, participants are strongly encouraged to take care of the hand-held computers, lock
them in a secure place, and to notify research staff immediately if the device malfunctions in
order to arrange a replacement device.
Alternative Treatments
In case of any discomfort from participating in this study, you can expect to
receive the following treatment or care which will be sought after by you and provided at
your expense: assistance from the UT Psychological Clinic (974-2161). In addition, a
referral list is available upon request for treatment centers not affiliated with the
university.
Confidentiality
To ensure that the information you provide us remains confidential, the data you provide
will be identified with a numeric code only and stored in a locked file cabinet. You will not be
personally identified in any reports or publications that may result from this study. None of the
information you provide us will be shared with anyone, including your counselors at
Cornerstone. The only exception to confidentiality is the duty to notify the appropriate
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authorities in compliance with state law if we become aware of the possibility of a participant
posing an imminent risk to him or herself or another, or if we become aware of the possibility
that child maltreatment is occurring. You may choose not to answer particular items on a
questionnaire or on the hand-held computers that you consider sensitive information or which
may place you at risk.
Voluntary Participation
You are free to decide whether or not to participate in this study, and you are free to
withdraw from the study at any time by informing the researchers and returning the handheld
computer. While withdrawing from the study at anytime will not result in any penalties, you will
not receive monetary compensation unless you return the handheld computer undamaged.
Authorization: I have read the above information and have received a copy of this form. The
purpose and the risk of this study have been explained to me. I agree to participate in this study.
Participant’s Signature

Printed Name

Signature of Principal Investigator or person obtaining consent

Date

Telephone

If you have further questions about this project, please contact Kathrin Ritter at (865) 974-8711.
For research-related problems or questions regarding subjects’ rights, the Institutional Review
Board may be contacted through the Compliance Office at 974-3466.
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Appendix D
Screening Questionnaire
1. What is the patient’s age? _____ (must be at least 18)
2. For what substance(s) is the patient seeking treatment? _____ (must be at least one drug other
than caffeine or nicotine)
3. Does patient speak English? _____

Ask patients the following questions to determine whether he/she meets criteria for a psychotic
disorder. Exclude patient if they endorse 1 or more items.
During the past two weeks……
1. Did things happen that you knew were true, but that other people told you were your
imagination?
2. Were you convinced that other people were watching you, talking about you, or spying on
you?
3. Did you think that you were in danger because someone was plotting to hurt you?
4. Did you think that you had special powers other people didn’t have?
5. Did you think that some outside force or power was controlling your body or mind?
6. Did you hear voices that other people didn’t hear, or see things that other people didn’t see?
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Appendix E
Demographic Questionnaire
1.

Age:_____

2.

Sex/Gender:

3.

Educational Background: Circle Highest Achieved

4.

Ethnic/Racial Background: Circle all that apply

5.

Religious Background/Affiliation: Circle all that apply

6.

Income Level: Circle One

7.

Employment Status:

8.

What is your current marital status?

9.

If you are currently dating someone or are married, how long have you been with this person?
total number of MONTHS together _____

10.

Sexual Orientation: Heterosexual / Gay / Lesbian / Bisexual

11.

If you answered “bisexual” to question 10 AND you are currently dating someone, what is the gender
of your current dating partner? Male / Female

Female / Male

1.
2.
3.
4.
5.

1.
2.
3.
4.
5.
1.
2.
3.
4.
5.
6.
7.

Less than high school diploma
High school graduate
Attended college/professionals school
Bachelor’s degree
Medical/Graduate degree

White/Caucasian
Black/African-American
Hispanic/Latino
Asian-American
Native American
Indian/Middle Eastern
Other (please list):_________________
1.
2.
3.
4.
5.
6.
7.

Catholic
Christian
Jewish
Muslim
Buddhist
Hindi
Other:__________________

Less than $25,000
$25,001 - $50,000
$50,001 - $100,000
$100,001 - $150,000
Greater than $150,000

1. Unemployed/on disability
2. Employed part-time
3. Employed full-time
1. Single
2. Dating
3. Married
4. Separated
5. Divorced
6. Widowed
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Appendix F
Structured Clinical Interview for DSM-IV
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Appendix G
Alcohol Use Disorders Identification Test (AUDIT)
The following questions ask about your use of alcoholic beverages during the 6 months before you started
treatment. For the following questions, 1 standard drink equals one can, glass, or 12 ounce bottle of beer, one
shot of liquor or mixed drink, or one glass of wine. Circle the answer below each item that best describes you.

1. How often do you have a drink containing alcohol?
Never
Monthly or Less
2 to 4 times a month
2 to 3 times a week
4 or more times a week

2. How many drinks containing alcohol do you have on a typical day when you are drinking?
0, 1 or 2
3 or 4
5 or 6
7 to 9
10 or more

3. How often do you have 4 (for women) / 5 (for men) or more drinks on one occasion?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

4. How often during the past 6 months have you found that you were not able to stop drinking
once you had started?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

5. How often during the past 6 months have you failed to do what was normally expected from
you because of drinking?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

6. How often during the past 6 months have you needed a drink first thing in the morning to get
yourself going after a heavy drinking session?
Never
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Less than monthly
Monthly
Weekly
Daily or almost daily

7. How often during the past 6 months have you had a feeling of guilt or remorse after drinking?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

8. How often during the past 6 months have you been unable to remember what happened the
night before because you had been drinking?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

9. In the past 6 months, have you or someone else been injured as a result of your drinking?
No
Yes, but not in the last six months
Yes, during the last six months

10. In the past 6 months, has a relative, friend, doctor, or other health worker been concerned
about your drinking or suggested you cut down?
No
Yes, but not in the last six months
Yes, during the last six months

11. Now think of all kinds of alcoholic beverages combined, that is - any combination of cans of
beer, glasses of wine, or drinks containing liquor of any kind. During the past 6 months, what is
the largest number of drinks you had on any single day? _______

12. How often during the past 6 months did you become intoxicated or drunk from drinking any
kind of beverage containing alcohol, whether it was wine, beer, whiskey, or any other drink?
Never
Less than monthly
About once a month
Several times a month
1-2 days a week
3-4 days a week
5-6 days a week
Every day
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Appendix H
Drug Use Disorders Identification Test (DUDIT)
The following questions ask about your use of drugs during the 6 months before you
started treatment. Please circle the answer that best describes you.
During the past 6 months:
1. About how often do you use cannabis (for example, hash, pot, marijuana, THC, or other)?
Never
Less than monthly
Monthly
2-3 times a month
Weekly
2 to 3 times a week
4 or more times a week

2. About how often do you use cocaine (for example, intranasal, IV, crack, freebase,
“speedball,” or other)?
Never
Less than monthly
Monthly
2-3 times a month
Weekly
2 to 3 times a week
4 or more times a week

3. About how often do you use hallucinogens / PCP (for example, LSD, mescaline, peyote,
psilocybin, STP, mushrooms, PCP, “angel dust,” Extasy, MDMA, or other)?
Never
Less than monthly
Monthly
2-3 times a month
Weekly
2 to 3 times a week
4 or more times a week

4. About how often do you use stimulants that were not prescribed for you by a doctor (for
example, amphetamine, “speed,” crystal meth, dexadrine, Ritalin, “ice,” or other)?
Never
Less than monthly
Monthly
2-3 times a month
Weekly
2 to 3 times a week
4 or more times a week

5. About how often do you use sedatives, hypnotics, or anxiolytics that were not prescribed for
you by a doctor (for example, Xanax, Quaaludes, Valium, Librium, barbiturates, Miltown,
Ativan, Dalmane, Halcion, Restoril, Seconal, or other)?
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Never
Less than monthly
Monthly
2-3 times a month
Weekly
2 to 3 times a week
4 or more times a week

6. About how often do you use opiates that were not prescribed for you by a doctor (for example,
heroin, morphine, Oxycontin, Hydrocodone, opium, Methadone, codeine, Demerol, Darvon,
Percodan, Dilaudid, or other)?
Never
Less than monthly
Monthly
2-3 times a month
Weekly
2 to 3 times a week
4 or more times a week

7. About how often do you use other substances, such as steroids, glue, gasoline, paint,
inhalants, nitrous oxide, “laughing gas,” amyl or butyl nitrate, “poppers,” nonprescription sleep
or diet pills, unknown, or other?
Never
Less than monthly
Monthly
2-3 times a month
Weekly
2 to 3 times a week
4 or more times a week

8. How often during the past 6 months have you found that you were not able to stop using drugs
once you had started?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

9. How often during the past 6 months have you failed to do what was normally expected from
you because of your drug use?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily
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10. How often during the past 6 months have you had a feeling of guilt or remorse after using
drugs?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

11. How often during the past 6 months have you been unable to remember what happened the
night before because you had been using drugs?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

12. How often during the past 6 months have you used drugs to keep yourself from experiencing
withdrawal symptoms?
Never
Less than monthly
Monthly
Weekly
Daily or almost daily

13. In the past 6 months, have you or someone else been injured as a result of your drug use?
No
Yes, but not in the last six months
Yes, during the last six months

14. In the past 6 months, has a relative or friend, or a doctor or other health worker been
concerned about your drug use or suggested you cut down or stop?
No
Yes, but not in the last six months
Yes, during the last six months
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Appendix I
Social Support Questionnaire
INSTRUCTIONS:
The following questions ask about people in your environment who provide you with help or
support. Each question has two parts. For the first part, list all people you know, excluding
yourself, whom you can count on for help or support in the manner described. Give the person’s
initials and their relationship to you (see example). Do not list more than one person next to each
of the letters beneath the question.
For the second part, circle how satisfied you are with the overall support you have.
If you have no support for a question, check the words “No one,” but still rate your level of
satisfaction. Do not list more than nine persons per question.
Please answer all questions as best you can. All your responses will be kept confidential.
EXAMPLE:
Who do you know whom you can trust with information that could get you in trouble?
No one
1) T.N. (brother)
2) L.M. (friend)
3) R.S. (friend)

4) T.N. (father)
5) L.M. (employer)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

1. Whom can you really count on to listen to you when you need to talk?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied
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2. Whom could you really count on to help you if a person whom you thought was a good friend
insulted you and told you that he/she didn’t want to see you again?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

3. Whose lives do you feel that you are an important part of?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

4. Whom do you feel would help you if you were married and had just separated from your
spouse?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

5. Whom could you really count on to help you out in a crisis situation, even though they would
have to go out of their way to do so?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)
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How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

6. Whom can you talk with frankly, without having to watch what you say?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

7. Who helps you feel that you truly have something positive to contribute to others?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

8. Whom can you really count on to distract you from your worries when you feel under stress?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

9. Whom can you really count on to be dependable when you need help?
No one
1)

4)

7)

1 – very
dissatisfied
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2)
3)

5)
6)

8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

10. Whom could you really count on to help you out if you had just been fired from your job or
expelled from school?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

11. With whom can you totally be yourself?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

12. Whom do you feel really appreciates you as a person?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied
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13. Whom can you really count on to give you useful suggestions that help you to avoid making
mistakes?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

14. Whom can you count on to listen openly and uncritically to your innermost feelings?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

15. Who will comfort you when you need it by holding you in their arms?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

16. Whom do you feel would help if a good friend of yours had been in a car accident and was
hospitalized in serious condition?
No one
1)
2)
3)
How satisfied?

4)
5)
6)

7)
8)
9)
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6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

17. Whom can you really count on to help you feel more relaxed when you are under pressure or
tense?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

18. Whom do you feel would help if a family member very close to you died?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

19. Who accepts you totally, including both your worst and best points?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

20. Whom can you really count on to care about you, regardless of what is happening to you?
No one
1)
2)

4)
5)

7)
8)
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3)

6)

9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

21. Whom can you really count on to listen to you when you are very angry at someone else?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

22. Whom can you really count on to tell you, in a thoughtful manner, when you need to improve
in some way?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

23. Whom can you really count on to help you feel better when you are feeling generally downin-the-dumps?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

24. Whom do you feel truly loves you deeply?

2 – fairly
dissatisfied

1 – very
dissatisfied
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No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

25. Whom can you count on to console you when you are very upset?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

26. Whom can you really count on to support you in major decisions you make?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied

27. Whom can you really count on to help you feel better when you are very irritable, ready to
get angry at almost anything?
No one
1)
2)
3)

4)
5)
6)

7)
8)
9)

How satisfied?
6 – very
satisfied

5 – fairly
satisfied

4 – a little
satisfied

3 – a little
dissatisfied

2 – fairly
dissatisfied

1 – very
dissatisfied
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Appendix J
Positive and Negative Affect Scales
This scale consists of a number of words that describe different feelings and emotions. Read each
item and then mark the appropriate answer in the space next to that word. Indicate to what
extent you generally feel this way, that is, how you feel on average. Use the following scale to
record your answers.
1
Very slightly
Or not at all
_____ interested
_____ excited
_____ strong
_____ scared
_____ enthusiastic

2
A little

3
Moderately

_____ irritable
_____ ashamed
_____ nervous
_____ attentive
_____ active

4
Quite a bit

5
Extremely

_____ distressed
_____ upset
_____ guilty
_____ hostile
_____ proud

_____ alert
_____ inspired
_____ determined
_____ jittery
_____ afraid
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